About Company

nse_stock_logo_png

PharmEasy (API Holdings Limited)

₹6.25

(+0.00 )

(0%)

5D

Invalid YouTube link

API Holdings Limited (Pharmeasy) Company Overview

API Holdings Limited is the parent company of PharmEasy, one of India’s largest and most recognised digital healthcare platforms. Headquartered in Mumbai, Maharashtra, the company operates across e-pharmacy, diagnostics, B2B pharmaceutical distribution, healthcare technology, and medical equipment supply.

API Holdings plays a central role in India’s outpatient (OPD) healthcare ecosystem, leveragin...

Information

  • PharmEasy (API Holdings Limited) Unlisted Shares Price

    ₹ 6.25 Per Equity Share

  • Lot Size

    2500 Shares

  • Depository

    BOTH

  • PAN Number

    AASCA1201E

  • ISIN Number

    INEODJ201029

  • CIN

    U60100MH2019PLC323444

  • RTA

    MUFG Intime India Pvt Ltd.

  • Market Cap (in cr.)

    ₹ 4591.85

  • P/E Ratio

    0

  • Book Value

    4.03

  • Face Value

    1

  • Total Shares

    7346959059

Financials(Figures in ₹ Crores)

Profit & Loss202320242025
Revenue6439.385664.295872.16
PAT-5229.55-2549.95-1593.19
EPS-7.12-3.47-2.17
Financial Ratio202320242025
Operating Profit Margin-11.05-9.75-9.42
Net Profit Margin-81.21-45.02-27.13
Earning Per Share (Diluted)-7.12-3.47-2.17
Balance Sheet - Assets202320242025
Fixed Assets337.89286.24268.75
CWIP3.062.7614.16
Investments338329.02179.19
Trade Receivables905.3706.21669.51
Inventory688.16555.56553.89
Other Assets5983.756501.875290.98
Total Assets8256.428389.666976.58
Balance Sheet - Liabilities202320242025
Share Capital614.2624.04651.67
Reserves1470.381556.862308.92
Borrowings4119.994098.362033.67
Trade Payables413.07412.91426.71
Other Liabilities1638.781697.491555.61
Total Liabilities8256.428389.666976.58

Related Blogs

From Cash Burn to Cash Discipline: PharmEasy’s Credible Path to Profitability by FY27
Unlisted Shares
Jan 5, 2026
4 min

From Cash Burn to Cash Discipline: PharmEasy’s Credible Path to Profitability by FY27

For years, PharmEasy symbolised the classic Indian startup trade-off: rapid scale funded by capital, but at the cost of sustained losses. Heavy discounts, fragmented operations, and expensive debt weighed down the balance sheet. Today, that narrative is changing. Under new leadership, the company has shifted decisively from growth-at-any-cost to profit-first execution. The stated goal is […]

Read More